BioNexus Gene Lab Corp. Payments for (Proceeds from) Investments
BioNexus Gene Lab Corp. (BGLC) reported Payments for (Proceeds from) Investments of $0 for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromInvestments · last filed 2020-03-31
- BioNexus Gene Lab Corp. payments for (proceeds from) investments for the quarter ending 2018-12-31 was -$5.00.
- BioNexus Gene Lab Corp. payments for (proceeds from) investments for the quarter ending 2018-09-30 was -$24.45K.
- BioNexus Gene Lab Corp. payments for (proceeds from) investments for fiscal 2018 was -$12.08K.
| Period end | Payments for (Proceeds from) Investments 3 month | Payments for (Proceeds from) Investments 6 month | Payments for (Proceeds from) Investments 9 month | Payments for (Proceeds from) Investments 12 month |
|---|---|---|---|---|
| 2019-06-30 | $0.00 10-Q · filed 2019-08-09 | |||
| 2018-12-31 | -$5.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | -$24.46K derived: sum of 2 quarters · filed 2020-03-31 | -$12.08K 10-K · filed 2020-03-31 | |
| 2018-09-30 | -$24.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$12.07K 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $12.38K 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |